Biosimilar

Hyrimoz

Biosimilar of:

HUMIRA

Active Ingredient: adalimumab

Drug Class: Biologics

Hyrimoz is not covered on the Reformulary. Reformulary Group has selected specific adalimumab biosimilars to be covered: AMGEVITA, manufactured by Amgen, and HULIO, manufactured by Viatris. AMGEVITA and HULIO are considered preferred biosimilars as they offer the same clinical value at a lower net cost to the plan. AMGEVITA and HULIO require Special Authorization.

Hyrimoz is used to treat  
Ankylosing Spondylitis
Hidradenitis Suppurativa
Inflammatory Bowel Disease (IBD)
Juvenile Idiopathic Arthritis
Psoriasis
Psoriatic Arthritis
Rheumatoid Arthritis
Uveitis